Techno Drugs (DHA:TECHNODRUG) Cash Flow for Dividends: BDT-0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:TECHNODRUG Techno Drugs Ltd DHA:TECHNODRUG
37 GF Score
Price BDT47.30
! 10 Warning Signs
View Full Analysis

What is Techno Drugs Cash Flow for Dividends?

Techno Drugs DHA:TECHNODRUG -2.27% 37 Cash Flow for Dividends is BDT-0 Mil as of Mar. 2026. GuruFocus rates DHA:TECHNODRUG with a GF Score™ of 37/100. The stock has 10 warning signs investors should review.

Techno Drugs's cash flow for dividends for the three months ended in Mar. 2026 was BDT0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was BDT-0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Techno Drugs's quarterly payment of dividends declined from Sep. 2025 (BDT-0 Mil) to Dec. 2025 (BDT0 Mil) but then stayed the same from Dec. 2025 (BDT0 Mil) to Mar. 2026 (BDT0 Mil).

Techno Drugs's annual payment of dividends stayed the same from . 20 (BDT0 Mil) to Jun. 2024 (BDT0 Mil) but then increased from Jun. 2024 (BDT0 Mil) to Jun. 2025 (BDT-49 Mil).


Techno Drugs Cash Flow for Dividends Related Terms


Techno Drugs Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Techno Drugs's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Techno Drugs Cash Flow for Dividends Chart

Techno Drugs Annual Data
Trend Jun24 Jun25
Cash Flow for Dividends
0.00 -49.42

Techno Drugs Quarterly Data
Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.31 0.00 0.00
DHA:TECHNODRUG
37GF Score
Techno Drugs Ltd DHA:TECHNODRUG
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Techno Drugs Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of BDT-0 Mil mean?
Techno Drugs (DHA:TECHNODRUG) has a Cash Flow for Dividends of BDT-0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Techno Drugs and its competitors.
Is Techno Drugs' Cash Flow for Dividends too high?
Techno Drugs' current Cash Flow for Dividends is BDT-0 Mil. Overall, Techno Drugs has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Techno Drugs' Cash Flow for Dividends compare to ZTS and UTHR?
Techno Drugs' Cash Flow for Dividends of BDT-0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Techno Drugs and its competitors. Techno Drugs's current Cash Flow for Dividends is BDT-0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Drugs stock overvalued right now?
Techno Drugs (DHA:TECHNODRUG) has a current Cash Flow for Dividends of BDT-0 Mil. The current Cash Flow for Dividends is BDT-0 Mil. Techno Drugs' overall GF Score™ is 37/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Techno Drugs (DHA:TECHNODRUG), the current Cash Flow for Dividends is BDT-0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Techno Drugs Business Description

Address 31 Segun Bagicha, J K Tower, Dhaka, BGD, 1000
Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.
37GF Score

Get the complete analysis for DHA:TECHNODRUG

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT47.30
Price